Dirk G. Brockstedt - Net Worth and Insider Trading

Dirk G. Brockstedt Net Worth

The estimated net worth of Dirk G. Brockstedt is at least $240,661 dollars as of 2024-12-13. Dirk G. Brockstedt is the EVP of Research and Dev. of Aduro Biotech Inc and owns about 14,521 shares of Aduro Biotech Inc (ADRO) stock worth over $212,007. Dirk G. Brockstedt is also the CHIEF SCIENTIFIC OFFICER of RAPT Therapeutics Inc and owns about 27,820 shares of RAPT Therapeutics Inc (RAPT) stock worth over $28,655. Details can be seen in Dirk G. Brockstedt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dirk G. Brockstedt has not made any transactions after 2024-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dirk G. Brockstedt

Dirk G. Brockstedt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dirk G. Brockstedt owns 3 companies in total, including RAPT Therapeutics Inc (RAPT) , Aduro Biotech Inc (ADRO) , and Chinook Therapeutics Inc (KDNY) .

Click here to see the complete history of Dirk G. Brockstedt’s form 4 insider trades.

Insider Ownership Summary of Dirk G. Brockstedt

Ticker	Comapny	Transaction Date	Type of Owner
RAPT	RAPT Therapeutics Inc	2024-01-05	Chief Scientific Officer
ADRO	Aduro Biotech Inc	2017-12-29	EVP of Research and Dev.
KDNY	Chinook Therapeutics Inc	2015-04-14	Sr. VP of Research and Dev.

Dirk G. Brockstedt Latest Holdings Summary

Dirk G. Brockstedt currently owns a total of 2 stocks. Among these stocks, Dirk G. Brockstedt owns 14,521 shares of Aduro Biotech Inc (ADRO) as of December 15, 2017, with a value of $212,007 and a weighting of 88.09%. Dirk G. Brockstedt also owns 27,820 shares of RAPT Therapeutics Inc (RAPT) as of January 5, 2024, with a value of $28,655 and a weighting of 11.91%.

Latest Holdings of Dirk G. Brockstedt

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ADRO	Aduro Biotech Inc	2017-12-15	14,521	14.60	212,007
RAPT	RAPT Therapeutics Inc	2024-01-05	27,820	1.03	28,655

Holding Weightings of Dirk G. Brockstedt

Dirk G. Brockstedt Form 4 Trading Tracker

According to the SEC Form 4 filings, Dirk G. Brockstedt has made a total of 0 transactions in Aduro Biotech Inc (ADRO) over the past 5 years. The most-recent trade in Aduro Biotech Inc is the sale of 13,045 shares on December 15, 2017, which brought Dirk G. Brockstedt around $528,958.

According to the SEC Form 4 filings, Dirk G. Brockstedt has made a total of 21 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in RAPT Therapeutics Inc is the sale of 898 shares on January 5, 2024, which brought Dirk G. Brockstedt around $20,456.

Insider Trading History of Dirk G. Brockstedt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dirk G. Brockstedt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dirk G. Brockstedt Ownership Network

Ownership Network List of Dirk G. Brockstedt

No Data

Ownership Network Relation of Dirk G. Brockstedt

Dirk G. Brockstedt Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Dirk G. Brockstedt is the Chief Scientific Officer of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Medical Officer William Ho , 10 percent owner Column Group Ii, Lp , and 10 percent owner Tcg Iv Gp, Llc .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, Dirk G. Brockstedt made 1 insider transaction in RAPT Therapeutics Inc (RAPT) with a net sale of 898. Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 9,000 shares made by William Ho ,

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,898 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

RAPT Therapeutics Inc Insider Transactions

No Available Data

What does Aduro Biotech Inc do?

Who are the key executives at Aduro Biotech Inc?

Dirk G. Brockstedt is the EVP of Research and Dev. of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .

Aduro Biotech Inc (ADRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aduro Biotech Inc Insider Transactions

No Available Data

What does Chinook Therapeutics Inc do?

Who are the key executives at Chinook Therapeutics Inc?

Dirk G. Brockstedt is the Sr. VP of Research and Dev. of Chinook Therapeutics Inc. Other key executives at Chinook Therapeutics Inc include Head of Renal Discovery Andrew James King , director & President & CEO Eric Dobmeier , and director & 10 percent owner Davis Jerel .

Chinook Therapeutics Inc (KDNY) Insider Trades Summary

Over the past 18 months, Dirk G. Brockstedt made no insider transaction in Chinook Therapeutics Inc (KDNY). Other recent insider transactions involving Chinook Therapeutics Inc (KDNY) include a net sale of 1,168 shares made by Andrew James King ,

In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,168 shares.

Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chinook Therapeutics Inc Insider Transactions

No Available Data

Dirk G. Brockstedt Mailing Address

Above is the net worth, insider trading, and ownership report for Dirk G. Brockstedt. You might contact Dirk G. Brockstedt via mailing address: C/o Aduro Biotech, Inc., 740 Heinz Avenue, Berkeley Ca 94710.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.